On May 13th and 14th 2020, the 4th Annual Global Clinical Trials Connect Conference will take place in London, UK. In the programme we find the description of the main theme of the meetings.
The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time, the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.
At MUUTAA we have recognized the need for AI and other technological applications in the clinical trial domain. We have developed several concrete concepts to advance trial recruitment and determine trial feasibility, today. We are bringing a number of projects to reality where these exciting advancements will be demonstrated and we will surely report the results shortly. Industry wide focus and the availability of early adopters will be essential to start demonstrating real impacts. Learn more on muutaa.com.